Added to YB: 2024-11-06
Pitch date: 2024-11-03
EPIX [bullish]
ESSA Pharma Inc.
+4.16%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Company Info
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.
Market Cap
$75.5M
Pitch Price
$0.19
Price Target
2.23 (+1008%)
Dividend
N/A
EV/EBITDA
1.15
P/E
-2.65
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
ESSA Pharma: Another Broken Biotech
EPIX: Clinical-stage pharma terminating all studies, reviewing strategic alternatives. $126.8M cash, $124.3M net working capital, no debt. 44.4M shares, 2.9M warrants. Est. $20M wind-down costs. Liquidation value ~40% above current price. $72M market cap vs. $126.8M cash.
Read full article (1 min)